
The main protein that the placenta produces is Human Chorionic Somatomammotropin (HCS). Although its precise biological functions are still not fully understood, it plays a significant role in regulating metabolism in pregnant women.
Radio-immunoassay makes it simple to quantify immunoreactive-HCS (1R-HCS) accurately. IR-HCS appears to correlate well with the maternal state in cases of hypertensive illness of pregnancy, but conclusive conclusions should wait until the conclusion of carefully monitored, substantial clinical trials.
The HCS molecule has a molecular mass of 22 125 Da, a single chain made up of 191 amino acid residues connected by two disulfide bridges and eight helices. X-ray diffraction was used to identify the 2.0 crystal structure of HCS.
Only during pregnancy is HCS present, and as the baby and placenta expand, so do maternal blood levels. Near-term maximum values are around 5-7 mg/L. There is a higher level of observance in patients who have had several pregnancies. The circulation of the fetus receives little HCS. It has a 15-minute biological half-life.
The following are some ways that HCS impacts the maternal organism's metabolic system:
Metabolic:
HCS in Clinical Measurement
Other pregnancy testing techniques determined have to be more trustworthy, despite the fact that HCS employed as a sign of fetal health and development. There have also been reports of healthy pregnancies with maternal HCS levels that are undetectable.
[wp-faq-schema title=" Full Form of HCS FAQs" accordion=1]
